Medicxi Ventures Management (Jersey) Ltd Long-Term Concentrated

Name: Medicxi Ventures Management (Jersey) Ltd Q1 2021 13F Filing | 13F Explorer
Creator: Medicxi Ventures Management (Jersey) Ltd
Published: 2021-05-11

Location: St. Helier, Jersey

CIK: 0001715579 · Show all filings

Period: Q1 2021 (← Previous) (Next →)

Filing Date: May 11, 2021

Total Value: $172M (100.0% shares, 0.0% debt)

Holdings (5)

PHAT PHATHOM PHARMACEUTICALS INC 45.2%

Value $77.67M Shares 2,067,861 Est. Cost $25.13 Unrealized +66.5%

PCVX VAXCYTE INC 21.7%

Value $37.28M Shares 1,887,478 Est. Cost $32.16 Unrealized -21.8%

— MERUS N V 19.5%

Value $33.42M Shares 1,600,000 Est. Cost $14.08 Unrealized —

— CHECKMATE PHARMACEUTICALS IN 10.6%

Value $18.23M Shares 1,501,716 Est. Cost $11.51 Unrealized —

— OBSEVA SA 3.0%

Value $5.102M Shares 1,570,000 Est. Cost $3.82 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
PHAT	PHATHOM PHARMACEUTICALS INC	2,067,861	$77.67M	45.2%	$25.13	+66.5%	COM	71722W107
PCVX	VAXCYTE INC	1,887,478	$37.28M	21.7%	$32.16	-21.8%	COM	92243G108
—	MERUS N V	1,600,000	$33.42M	19.5%	$14.08	—	COM	N5749R100
—	CHECKMATE PHARMACEUTICALS IN	1,501,716	$18.23M	10.6%	$11.51	—	COM	162818108
—	OBSEVA SA	1,570,000	$5.102M	3.0%	$3.82	—	COM	H5861P103